FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to neurology, and can be used for treating migraine. That is ensured by introducing a formulation containing diclofenac 50 mg or its pharmaceutically acceptable salt. The Cmax value makes approximately 1500 to approximately 2500 ng/ml, while the tmax value makes approximately 10 to approximately 25 minutes.
EFFECT: method provides fast and prolonged relieve of migraine and its symptoms within two hours following introduction of the preparation due to fast bioavailability and prolongation of a therapeutic window.
9 cl, 1 dwg, 15 tbl, 12 ex
| Title |
Year |
Author |
Number |
| SUBLINGUAL COATED TABLET |
2006 |
- Uri Paskal'
- Benuas Gijom
- Ehrri Katrin
- Djuvoshel' Zhozef
|
RU2403043C2 |
| INTRANASAL PHARMACEUTICAL POWDER COMPOSITIONS |
2017 |
|
RU2818086C2 |
| SODIUM IBUPROFEN TABLETS AND METHODS FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING SODIUM IBUPROFEN |
2010 |
- Seyer Jeffery J.
- Konder Amy L.
- Taylor Angela P.
- Shaw Bonny Rene
|
RU2715680C2 |
| WAY OF RECEPTION OF PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS CONTAINING FIBRATE AND TABLETS MADE IN THIS WAY |
2004 |
|
RU2362547C2 |
| COMPOSITIONS OF SOLID DOSAGE FORMS OF AN OREXIN RECEPTOR ANTAGONIST |
2013 |
- Kharmon Pol A.
- Variankaval Narayan
|
RU2699358C2 |
| COMPOSITIONS OF SOLID DOSAGE FORMS OF OREXIN RECEPTOR ANTAGONIST |
2013 |
- Kharmon, Pol, A.
- Variankaval, Narayan
|
RU2759837C2 |
| BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE |
2015 |
- Martin, Andrea K.
- Kanski, Jaroslaw
- Bera, Bindu
- Bera, Sanjib
- Guenther, Sven
- Mickle, Travis
|
RU2683317C2 |
| TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS |
2009 |
- Gordon Robert D.
- Khol'M Per
- Lejdmann Anne-Marie
|
RU2574006C2 |
| PHARMACEUTICAL COMPOSITIONS AGAINST HEADACHE, MIGRAINE, SICKNESS, AND RETCH |
2001 |
- Barkan Rafaehl'
- Mirimskij Aleksandr
|
RU2275905C2 |
| METHODOLOGY PREPARATIONS |
2014 |
|
RU2684914C2 |
